维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="DELASALLE K"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Primary dexamethasone treatment of multiple myeloma 显示文摘	ALEXANIAN R DIMOPOULOS M A DELASALLE K	1992	Blood1992，80，：	1
2	Primary dexamethasone treatment of multiple myeloma显示文摘	Alexanian R Dimopoulos MA Delasalle K	1992	Blood1992，80，：	1
3	Complete remission represents the major surrogate worker of long survival in myeloma 显示文摘	WANG M DELASALLE K THOMAS S	2006	Blood2006，108，11：	1
4	Primary dexamethasone treatment of multiple myeloma显示文摘	Alexanian R Dimopoulos MA Delasalle K	1992	Blood1992，80，4：	1
5	Prognostic value of cytogenetics in multiple myeloma显示文摘	Secng C Delasalle K Hayes K	1998	Br J Haematol1998，101，：	1
6	Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma 显示文摘	Wang M Weber DM Delasalle K	2005	Am J Hematol2005，79，3：	1
7	Primary dexamethasone treatment of multiple myeloma显示文摘	Alexanian R Dimopoulos MA Delasalle K	1992	Blood1992，80，4：	1
8	2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia显示文摘	WEBER DONNA M DIMOPOULOS MELETIOS A DELASALLE K	2003	Semin Oncol2003，30，：	1
9	Thalidomide alone or with dexamethasone for multiple myeloma显示文摘	Weber DM Gavino M Delasalle K	1999	Blood1999，941，：	1
10	Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma显示文摘	Wang M Weber DM Delasalle K	2006	Am J Hematol2006，81，5：	1
11	Primary dexamethasone treatment of multiple myeloma显示文摘	Alexanian R Dimopoulos MA Delasalle K	1992	Blood1992，80，4：	1
12	2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom 's macroglobulinemia显示文摘	WEBER D M DtMoPoULOS M A DELASALLE K	2003	Semin Oncol2003，30，2：	1
13	套细胞淋巴瘤的免疫治疗显示文摘套细胞淋巴瘤(MCL)是一种恶性侵袭性非霍奇金淋巴瘤,以出现t(11;14)(q13;q32)以及细胞周期蛋白D1(Cyclin D1)过度表达为特征,预后很差.近年来,生物学、遗传学以及免疫学的发展推动了MCL的免疫治疗.单用利妥昔单抗的疗效有限,但将其与其他化疗方案如CHOP(环磷酰胺联合多柔比星、长春新碱、泼尼松)、hyperCVAD/MTX-Ara-C(高剂量环磷酰胺联合长春新碱、多柔比星、地塞米松与甲氨蝶呤或阿糖胞苷交替)、FCM(氟达拉滨联合环磷酰胺、米托蒽醌)等联合之后,无论作为MCL的一线治疗还是挽救治疗,疗效均有明显改善.利妥昔单抗用于维持治疗或与自体造血干细胞移植联合后可延长缓解持续时间.此外,替伊莫单抗以及妥司莫单抗、异基因造血干细胞移植、供者淋巴细胞输注、树突状细胞、独特型疫苗联合等,其他的免疫治疗如沙利度胺和雷利度胺联合利妥昔单抗在复发性或难治性MCL中也取得了一定进展.	路瑾王华庆黄晓军周宇红王鲁华 Delasalle K 房文晶	2008	白血病.淋巴瘤2008，17，1：	1
14	Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma显示文摘	Wang M Giralt S Delasalle K	2007	Hematology2007，12，3：	1
15	2-Chlorodeoxyadenosine alone and in combi- nation for previously untreated Waldenstrom's macro- globulinemia显示文摘	WEBER D M DIMOPOULOS M A DELASALLE K	2003	Semin Oncol2003，30，：	1
16	Rapid control of previously untreated multiple myeloma with bortezomib-thalidomide-dexamethasone followed by early intensive therapy 显示文摘	Wang M Delasalle K Giralt S	2005	Blood2005，106，11：	1
17	Primary dexamethasone treatment of multiple myeloma显示文摘	Alexanian R Dimopoulos MA Delasalle K	1992	Blood1992，80，4：	1
18	2- Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia显示文摘	Weber DM Dimopoulos MA Delasalle K	2003	Semin Oncol2003，30，2：	1
19	Primary dexamethasone treatment of multiple myeloma显示文摘	Alexanian R Dimopoulos MA Delasalle K	1992	Blood1992，80，4：	1
20	Confirmation of prognostic value of model using 132-microglobulin and al- bumin for multiple myeloma proposed by the interna- tional myeloma working group with similar results using 132M alone显示文摘	Weber DM Wang M Delasalle K	2003	Blood2003，102，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示